CN108530510A - A kind of C19- is acylated the preparation method of triptolide - Google Patents

A kind of C19- is acylated the preparation method of triptolide Download PDF

Info

Publication number
CN108530510A
CN108530510A CN201710121312.1A CN201710121312A CN108530510A CN 108530510 A CN108530510 A CN 108530510A CN 201710121312 A CN201710121312 A CN 201710121312A CN 108530510 A CN108530510 A CN 108530510A
Authority
CN
China
Prior art keywords
compound
group
formula
oxidations
triptolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710121312.1A
Other languages
Chinese (zh)
Inventor
张鹏
刘祥超
荣彬
刘娜
王盼
包丽霞
贺利军
仇波
肖飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XINKAI MEDICAL TECHNOLOGY (SHANGHAI) Co Ltd
XINKAI MEDICAL CHEMICAL INTERMEDIATE (SHANGHAI) CO Ltd
Original Assignee
XINKAI MEDICAL TECHNOLOGY (SHANGHAI) Co Ltd
XINKAI MEDICAL CHEMICAL INTERMEDIATE (SHANGHAI) CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XINKAI MEDICAL TECHNOLOGY (SHANGHAI) Co Ltd, XINKAI MEDICAL CHEMICAL INTERMEDIATE (SHANGHAI) CO Ltd filed Critical XINKAI MEDICAL TECHNOLOGY (SHANGHAI) Co Ltd
Priority to CN201710121312.1A priority Critical patent/CN108530510A/en
Publication of CN108530510A publication Critical patent/CN108530510A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The present invention provides the preparation methods that a kind of C19 is acylated triptolide, and specifically, the method for the present invention is prepared C19 by carrying out monoacylation to compound of formula I, by three-step reaction and is acylated triptolide.The present invention overcomes the bad disadvantage of regioselectivity in existing method, high income, raw material availability is high.

Description

A kind of C19- is acylated the preparation method of triptolide
Technical field
The invention belongs to organic chemistry, pharmaceutical chemistry and field of natural medicinal chemistry, specifically relate to a kind of C19- acylations thunder The preparation method of public rattan A prime.
Background technology
Tripterygium wilfordii (Triptergium wilfordii Hook.f) is the annual liana of Celastraceae, is China's tradition A kind of common Chinese herbal medicine in medicine.Its is warm-natured, bitter and puckery flavor, has anti-inflammatory, antirheumatic, analgesic isoreactivity.Triptolide is again Claim triptolide, is one of main active of tripterygium wilfordii.It mainly extracts from the leaf of tripterygium wilfordii and root and obtains, tool There are the multiple biological activities such as immunosupress, anti-inflammatory, antifertility, antitumor, desinsection, is clinically used for treatment psoriasis, rheumatoid Arthritis, leukaemia, nephrosis etc., but its toxicity is the main reason for restricting such compound clinical application.C19- benzoylations Triptolide refers to 19 derivatives obtained after introducing benzoyl in tripterygium wilfordii, shows apparent antitumor work Property, while the toxicity of the compound has apparent attenuating compared with triptolide, has good clinical development foreground.
The existing synthetic method about C19- benzoylation triptolides only has one kind, CN 1925852A and WO It is had been described in 2005/084365 A2.Specific synthetic route is as follows:
Dibenzoyl is obtained by the reaction using the triptolide of C14 hydroxyl protections as raw material, with chlorobenzoyl chloride in the route Derivative, then removing first sulfidomethyl obtains dibenzoyl triptolide under mercury chloride effect, finally again in acid item Hydrolysis obtains single benzoyl compound under part.This synthetic route takes the strategy that first bisacylation hydrolyzes again, causes in this way The waste of raw material;Meanwhile acylating reagent is adopted benzoyl chloride as in one step of double acylations, reagent needs are significantly excessive, and It seriously causes yield relatively low with LDA side reactions.So this route cost is higher, poor operability is not suitable for industrial metaplasia Production.
In conclusion there is an urgent need in the art to a kind of methods for preparing C19- and being acylated triptolide.
Invention content
The object of the present invention is to provide a kind of methods for preparing C19- and being acylated triptolide.
The first aspect of the present invention provides a kind of preparation method of C19- acylation triptolides (IV), the side Method includes step:
(a) in atent solvent, under alkaline condition, with formula (I) compound and aldehyde compound R2- CHO reacts, and obtains Formula (II) compound:
(b) in atent solvent, oxidation reaction is carried out with formula (II) compound, to obtain formula (III) compound:
(c) in atent solvent, formula (III) compound deprotection group obtains formula (IV) compound:
Wherein R1For first sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, contains C3-C8 naphthenic base The 1-4 heteroatomic 5-10 circle heterocyclic rings bases for being selected from N, O or S.
In another preferred example, the step (c) is in HgCl2In the presence of carry out.
In another preferred example, in the step (c), the atent solvent is selected from the group:Acetonitrile, water or its group It closes.
In another preferred example, R1For first sulfidomethyl, R2For phenyl.
In another preferred example, in the step a), the reaction carries out in the presence of alkali selected from the group below:Two is different Propyl amido lithium (LDA), n-BuLi (n-BuLi), tert-butyl lithium (t-BuLi), hexamethyldisilazide lithium (LiHMDS), Two silicon substrate amido (NaHMDS) of hexamethyl, sodium hydride (NaH).
In another preferred example, in the step (a), the ratio of the alkali and formula (I) compound is (0.8- 4.0):1, preferably (1.0-2.0):1.
In another preferred example, described with aldehyde compound R in the step (a)2- CHO and formula (I) compound Ratio be (0.8-3.0):1, preferably (1.0-2.0):1.
In another preferred example, in the step (b), the ratio of the compound ii and oxidant is (0.8- 3.0):1, preferably (1.0-2.0):1.
In another preferred example, in the step (a), the atent solvent is selected from the group tetrahydrofuran and ether, It is preferred that tetrahydrofuran.
In another preferred example, in the step (a), the reaction temperature be -78~25 DEG C, preferably -78~0 ℃。
In another preferred example, in the step (a), the reaction time be 30 minutes~24 hours, preferably 60 Minute~12 hours.
In another preferred example, the method for oxidation used in the oxidation reaction described in step (b) is selected from the group:Dess- Martin is aoxidized, IBX oxidations, Swern oxidations, Moffatt oxidations, MnO2Oxidation, SeO2Oxidation, Collins oxidations, Jones oxygen Change, PCC oxidations, PDC oxidations.
In another preferred example, in the step (b), oxidising agent is selected from down used in the oxidation reaction Group:Dess-Martin oxidants, IBX oxidants, Swern oxidants, Moffatt oxidants, MnO2Oxidant, SeO2Oxidation Agent, Collins oxidants, Jones oxidants, PCC oxidants, PDC oxidants.
In another preferred example, in the step (b), the atent solvent is selected from the group:Ethyl acetate, dichloromethane Alkane, chloroform, tetrahydrofuran, ether, acetonitrile, Isosorbide-5-Nitrae-dioxane, n,N-Dimethylformamide, n,N-dimethylacetamide, two First sulfoxide, or combinations thereof.
In another preferred example, in the step (b), the reaction temperature is 0~25 DEG C.
In another preferred example, in the step (b), the reaction time be 30 minutes~24 hours, preferably 60 Minute~12 hours.
In another preferred example, the R2It is selected from the group:Phenyl, 2- furyls, 3- furyls, 2- thienyls, 3- thiophenes Pheno base, 2- pyridyl groups, 3- pyridyl groups, 4- pyridyl groups, C1-C10 alkyl.
The second aspect of the present invention provides a kind of preparation method of C19- acylation triptolides (IV), feature It is, the method includes the steps:
C) in atent solvent, formula (III) compound deprotection group obtains formula (IV) compound:
Wherein, the definition of each group is as described in first aspect present invention.
In another preferred example, the method further includes step:
B) in atent solvent, oxidation reaction is carried out with formula (II) compound, to obtain formula (III) compound.
It is intermediate to provide a kind of C19- acylation triptolide preparations being shown below for the third aspect of the present invention Body:
Wherein, X is selected from the group:-OH、O;
Wherein R1It is selected from the group:First sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, C3-C8 cycloalkanes Base, the heteroatomic 5-10 unit's heteroaryls for being selected from N, O or S containing 1-4;
Dotted line indicates chemical bond or nothing.
It should be understood that within the scope of the present invention, above-mentioned each technical characteristic of the invention and have in below (eg embodiment) It can be combined with each other between each technical characteristic of body description, to form a new or preferred technical solution.As space is limited, exist This no longer tires out one by one states.
Specific implementation mode
The present inventor in-depth study by long-term, it has unexpectedly been found that a kind of C19- is acylated the system of triptolide Preparation Method, the preparation method use compound of formula I as raw material, it is possible to prevente effectively from incidental double in the prior art Site acylation reaction, raw material availability are high.And the method can be used for a series of preparation of related activity compounds.
Term
As used herein, " C1-C6 alkyl " refers to the alkyl for the linear chain or branched chain for including 1-6 carbon atom, such as methyl, Ethyl, propyl, isopropyl, butyl, isobutyl group, tertiary butyl or similar group.
As used herein, " C3-C8 naphthenic base " refers to including the naphthenic base of 3-8 carbon atom, such as cyclopropyl, ring fourth Base, cyclopenta, cyclohexyl or similar group.
As used herein, " 5-10 circle heterocyclic rings base " refers to the ring group for including 5-10 annular atom, and the ring group can be It is all unsaturated, part insatiable hunger and/or with armaticity, such as cyclopropyl, cyclobutyl, pyrrole radicals, morpholinyl or similar base Group.
C19- is acylated the synthesis of triptolide
The purpose of the present invention is overcoming the deficiencies in the prior art, a kind of novel formula (IV) C19- acylations thunder is provided The synthetic method of public rattan A prime.
The present invention provides the preparation methods that a kind of C19- is acylated triptolide (IV), include the following steps:
A) formula (II) compound is reacted with aldehyde compound by formula (I) compound under alkaline condition, reaction equation is such as Under:
B) formula (III) compound is reacted under oxidant effect by formula (II) compound, reaction equation is as follows:
C) formula (III) compound deprotection group obtains formula (IV) compound, and reaction equation is as follows:
Wherein R1 is first sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, contains C3-C8 naphthenic base The 1-4 heteroatomic 5-10 unit's heteroaryls for being selected from N, O or S.R1For first sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, C3-C8 naphthenic base, the heteroatomic 5-10 circle heterocyclic rings base for being selected from N, O or S containing 1-4, preferably R1 are first sulphur Methyl, R2For phenyl.
The alkali used in condensation reaction described in step (a) is selected from lithium diisopropyl amido (LDA), n-BuLi (n- BuLi), tert-butyl lithium (t-BuLi), hexamethyldisilazide lithium (LiHMDS), sodium hexamethyldisilazide (NaHMDS), Sodium hydride (NaH), preferably lithium diisopropyl amido (LDA);The ratio of alkali and formula (I) compound is (0.8-4.0):1, preferably (1.0-2.0):1。
Condensation reaction described in step (a) carries out in a solvent, solvent used be tetrahydrofuran and ether, preferably four Hydrogen furans;- 78~25 DEG C of temperature used, preferably -78~0 DEG C;Reaction time be 0.5 hour~24 hours, preferably 1 hour~12 Hour.
The method for oxidation used in oxidation reaction described in step (b) aoxidizes for Dess-Martin, IBX oxidations, Swern Oxidation, Moffatt oxidations, MnO2Oxidation, SeO2Oxidation, Collins oxidations, Jones oxidations, PCC oxidations, PDC oxidations, preferably Dess-Martin is aoxidized, MnO2Oxidation, Swern oxidations.
The oxidation reaction used in oxidation reaction described in step (b) carries out in a solvent, and solvent for use is ethyl acetate, Dichloromethane, chloroform, tetrahydrofuran, ether, acetonitrile, Isosorbide-5-Nitrae-dioxane, n,N-Dimethylformamide, N, N- dimethylacetamides One or more of amine, dimethyl sulfoxide, ethyl acetate, dichloromethane.
In a preferred experimental program of the invention, the complete synthetic route of C19- benzoyl triptolides is such as Shown in lower:
In the present invention, the intermediate being prepared such as formula (II) and formula (III) compound can be further used for preparing Other C-19 benzoyl triptolide intermediates or prodrug.For example, can be used for preparing formula (V) compound:
D) in atent solvent, with formula (II) compound deprotection group, formula (V) compound is obtained:
The advantages of present invention is relative to existing synthetic route:
1) regioselectivity of the reaction is more preferable, avoids C18 and C19 while being acylated;
2) the reaction yield higher, the very big utilization rate for improving raw material;
3) application range of the reaction is wider, and target acylate but also the corresponding alcohols of synthesis can be obtained by the method Intermediate and related derivative product.
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention Rather than limit the scope of the invention, it is reference with this technology, it is modified or improved and belongs to protection scope of the present invention It is interior.In the following examples, the experimental methods for specific conditions are not specified, usually according to normal condition, or according to proposed by manufacturer Condition.Unless otherwise stated, otherwise percentage and number are calculated by weight.
The synthesis of 1 C19- benzoyl triptolides of embodiment
Step 1)
Under argon gas protection, compound 1 (1.26g, 3.0mmol) is dissolved in dry tetrahydrofuran (30mL), has been stirred - 78 DEG C are gradually cooled to after fully dissolved, be slowly added dropwise at this temperature heptane/ethylbenzene/tetrahydrofuran LDA solution (2.4mL, 3.6mmol).Drop finishes, and benzaldehyde (0.48mL, 4.5mmol) is slowly added dropwise after this temperature continues stirring 30 minutes.It then will be anti- It answers system to be warmed to room temperature naturally and is stirred to react overnight.
Reaction terminates, and after reaction solution is cooled to 0 DEG C plus water (5mL) is quenched.It is concentrated under reduced pressure and removes most of tetrahydrofuran, Gained mixed liquor is extracted with ethyl acetate (25mL × 3).Merge organic phase, anhydrous sodium sulfate drying is concentrated under reduced pressure, and gained slightly produces Object passes through column chromatography (200-300 mesh silica gel, n-hexane:Ethyl acetate=4:1) purifying obtains target product 1.0g (yields 62%).1H NMR(CDCl3)δ:7.44-7.35 (m, 5H), 5.07-4.89 (m, 4H), 3.74 (m, 1H), 3.51 (m, 1H), 2.64-2.53 (m, 2H), 2.38-2.31 (m, 1H), 1.09-1.01 (m, 6H), 0.84 (d, J=8.0Hz, 3H)
Step 2)
Under argon gas protection, compound 2 (1.0g, 1.9mmol) is dissolved in dry dichloromethane (30mL), stirring is complete Postcooling is dissolved to 0 DEG C, is slowly added to Dess-Martin oxidants (0.97g, 2.3mmol) in batches.Drop finishes, and rises to room naturally Temperature simultaneously continues to be stirred to react 2h.
Reaction terminates, and dichloromethane (20mL) is added and dilutes, and is filtered to remove most of insoluble solids, organic phase is respectively with full With sodium bicarbonate (20mL), water (10mL) and saturated salt solution (10mL) washing, anhydrous sodium sulfate drying are concentrated under reduced pressure, gained Crude product passes through column chromatography (200-300 mesh silica gel, n-hexane:Ethyl acetate=5:1) purifying obtains target product 0.51g (productions Rate 50%).1H NMR(CDCl3)δ:8.04 (d, J=8.0Hz, 2H), 7.66 (t, J=8.0Hz, 1H), 7.52 (d, J= 8.0Hz, 2H), 5.88 (s, 1H), 5.07 (d, J=12.0Hz, 1H), 4.95 (d, J=12.0Hz, 1H), 3.81 (d, J= 4.0Hz, 1H), 3.66 (s, 1H), 3.51 (d, J=4.0Hz, 1H), 3.18 (d, J=8.0Hz, 1H), 2.94 (m, 1H), 2.38- 2.32(m,2H),2.24-2.18(m,1H),2.19(s,3H),1.93-1.86(m,1H),1.64-1.58(m,2H),1.11(s, 3H), 1.01 (d, J=8.0Hz, 3H), 0.83 (d, J=8.0Hz, 3H)13C NMR(CDCl3)δ:191.95,171.40, 160.25,134.57,134.51,129.56,128.95,127.38,81.70,75.93,64.36,63.90,61.58, 58.16,55.15,54.57,40.92,39.24,36.05,33.23,31.59,30.60,29.49,29.10,28.60, 26.37,24.54,23.72,23.32,22.66,20.23,17.42,17.29,17.17,17.03,16.95,16.50, 14.85,14.55,14.14,14.05,13.87.
Step 3)
At room temperature, compound 3 (505mg, 0.96mmol) is dissolved in acetonitrile (8mL), solid mercury dichloride is added Reaction is stirred at room temperature overnight in (2.6g, 9.6mmol) and water (2mL).Reaction terminates, and is filtered to remove insoluble solids, mother liquid obtained to add Ethyl acetate (100mL) dilute, respectively use saturated sodium-chloride (10mL × 3), saturated ammonium chloride (10mL × 3), water (10mL) and Saturated salt solution (10mL) washs, and organic phase is dried with anhydrous sodium sulfate, is concentrated under reduced pressure, gained crude by column chromatography (200- 300 mesh silica gel, n-hexane:Ethyl acetate=4:1) purifying obtains target product 0.21g (yield 60%).1H NMR(CDCl3)δ: 8.04 (d, J=8.0Hz, 2H), 7.66 (t, J=8.0Hz, 1H), 7.53 (t, J=8.0Hz, 2H), 5.89 (s, 1H), 3.92 (d, J=4.0Hz, 1H), 3.53 (d, J=4.0Hz, 1H), 3.40 (d, J=12.0Hz, 1H), 3.32 (d, J=4.0Hz, 1H), 2.97-2.94 (m, 1H), 2.74 (d, J=12.0Hz, 1H), 2.40-2.16 (m, 4H), 1.59-1.55 (m, 2H), 1.33- 1.24 (m, 4H), 1.14 (s, 3H), 1.01 (d, J=8.0Hz, 3H), 0.89 (d, J=8.0Hz, 3H)13C NMR(CDCl3)δ: 191.88,171.29,160.04,134.62,134.48,129.56,128.97,127.29,81.58,73.44,66.18, 65.58,60.80,60.20,56.86,54.46,40.87,35.95,29.30,28.15,23.86,17.75,17.38, 16.87,13.83.
The synthesis of embodiment 2 C19- (Hydroxybenzylated) triptolide
At room temperature, compound 2 (53mg, 0.1mmol) is dissolved in acetonitrile (8mL), solid mercury dichloride (270m is added G, 1.0mmol) and water (2mL), reaction is stirred at room temperature overnight.Reaction terminates, and is filtered to remove insoluble solids, mother liquid obtained plus acetic acid Ethyl ester (50mL) dilutes, and uses saturated sodium-chloride (10mL × 3), saturated ammonium chloride (10mL × 3), water (10mL) and saturation food respectively Brine (10mL) washs, and organic phase is dried with anhydrous sodium sulfate, is concentrated under reduced pressure, gained crude by column chromatography (200-300 mesh silicon Glue, n-hexane:Ethyl acetate=4:1) purifying obtains target product 25m g (yield 51%).
All references mentioned in the present invention is incorporated herein by reference, independent just as each document It is incorporated as with reference to such.In addition, it should also be understood that, after reading the above teachings of the present invention, those skilled in the art can To be made various changes or modifications to the present invention, such equivalent forms equally fall within model defined by the application the appended claims It encloses.

Claims (10)

1. a kind of C19- is acylated the preparation method of triptolide (IV), which is characterized in that the method includes the steps:
(a) in atent solvent, under alkaline condition, with formula (I) compound and aldehyde compound R2- CHO reacts, and obtains formula (II) compound:
(b) in atent solvent, oxidation reaction is carried out with formula (II) compound, to obtain formula (III) compound:
(c) in atent solvent, formula (III) compound deprotection group obtains formula (IV) compound:
Wherein R1For first sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, contains 1-4 at C3-C8 naphthenic base Heteroatomic 5-10 circle heterocyclic rings base selected from N, O or S.
2. the method as described in claim 1, it is characterised in that:R1For first sulfidomethyl, R2For phenyl.
3. the method as described in claim 1, which is characterized in that in the step a), the reaction is selected from the group below It is carried out in the presence of alkali:Lithium diisopropyl amido (LDA), n-BuLi (n-BuLi), tert-butyl lithium (t-BuLi), two silicon of hexamethyl Base amido lithium (LiHMDS), two silicon substrate amido (NaHMDS) of hexamethyl, sodium hydride (NaH).
4. the method as described in claim 1, which is characterized in that in the step (a), the alkali and formula (I) compound Ratio be (0.8-4.0):1, preferably (1.0-2.0):1.
5. the method as described in claim 1, which is characterized in that in the step (a), the atent solvent is selected from the group Tetrahydrofuran and ether, preferably tetrahydrofuran.
6. the method as described in claim 1, which is characterized in that the method for oxidation used in oxidation reaction described in step (b) It is selected from the group:Dess-Martin is aoxidized, IBX oxidations, Swern oxidations, Moffatt oxidations, MnO2Oxidation, SeO2Oxidation, Collins is aoxidized, Jones oxidations, PCC oxidations, PDC oxidations.
7. the method as described in claim 1, which is characterized in that in the step (b), the atent solvent is selected from down Group:Ethyl acetate, dichloromethane, chloroform, tetrahydrofuran, ether, acetonitrile, Isosorbide-5-Nitrae-dioxane, n,N-Dimethylformamide, N, N- dimethylacetylamides, dimethyl sulfoxide, or combinations thereof.
8. the method as described in claim 1, which is characterized in that the R2It is selected from the group:Phenyl, 2- furyls, 3- furans Base, 2- thienyls, 3- thienyls, 2- pyridyl groups, 3- pyridyl groups, 4- pyridyl groups, C1-C10 alkyl.
9. a kind of C19- is acylated the preparation method of triptolide (IV), which is characterized in that the method includes the steps:
C) in atent solvent, formula (III) compound deprotection group obtains formula (IV) compound:
Wherein, the definition of each group is as described in the appended claim 1.
10. a kind of C19- being shown below is acylated triptolide and prepares intermediate:
Wherein, X is selected from the group:-OH、O;
Wherein R1It is selected from the group:First sulfidomethyl, acetyl group, trimethylsilyl, R2For phenyl, C1-C10 alkyl, contains C3-C8 naphthenic base There are the 1-4 heteroatomic 5-10 unit's heteroaryls for being selected from N, O or S;Dotted line indicates chemical bond or nothing.
CN201710121312.1A 2017-03-02 2017-03-02 A kind of C19- is acylated the preparation method of triptolide Pending CN108530510A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710121312.1A CN108530510A (en) 2017-03-02 2017-03-02 A kind of C19- is acylated the preparation method of triptolide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710121312.1A CN108530510A (en) 2017-03-02 2017-03-02 A kind of C19- is acylated the preparation method of triptolide

Publications (1)

Publication Number Publication Date
CN108530510A true CN108530510A (en) 2018-09-14

Family

ID=63489317

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710121312.1A Pending CN108530510A (en) 2017-03-02 2017-03-02 A kind of C19- is acylated the preparation method of triptolide

Country Status (1)

Country Link
CN (1) CN108530510A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110551170A (en) * 2018-05-31 2019-12-10 欣凯医药化工中间体(上海)有限公司 Synthesis method of C-19 single-acyl triptolide derivative
CN110551171A (en) * 2018-05-31 2019-12-10 欣凯医药化工中间体(上海)有限公司 preparation method of triptolide derivative

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1925852A (en) * 2004-03-02 2007-03-07 美国泛华医药公司 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
CN101235041A (en) * 2007-10-26 2008-08-06 北京美迪克斯生物技术有限公司 Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof
CN101255186A (en) * 2008-04-10 2008-09-03 中国科学院上海药物研究所 Tripterygium wilfordii diterpenes diterpenoids lactones derivative and uses thereof
CN104513290A (en) * 2013-10-08 2015-04-15 中国医学科学院药物研究所 Triptolidenol derivative and application thereof
CN105121455A (en) * 2013-12-11 2015-12-02 香港浸会大学 C-19 modified triterpenoids with hiv maturation inhibitory activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1925852A (en) * 2004-03-02 2007-03-07 美国泛华医药公司 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
CN101235041A (en) * 2007-10-26 2008-08-06 北京美迪克斯生物技术有限公司 Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof
CN101255186A (en) * 2008-04-10 2008-09-03 中国科学院上海药物研究所 Tripterygium wilfordii diterpenes diterpenoids lactones derivative and uses thereof
CN104513290A (en) * 2013-10-08 2015-04-15 中国医学科学院药物研究所 Triptolidenol derivative and application thereof
CN105121455A (en) * 2013-12-11 2015-12-02 香港浸会大学 C-19 modified triterpenoids with hiv maturation inhibitory activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XU HONGTAO ET AL.: "Design,Synthesis and Structure-Activity Relationships Studies on the D Ring of the Natural Product Triptolide", 《CHEMMED COMM》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110551170A (en) * 2018-05-31 2019-12-10 欣凯医药化工中间体(上海)有限公司 Synthesis method of C-19 single-acyl triptolide derivative
CN110551171A (en) * 2018-05-31 2019-12-10 欣凯医药化工中间体(上海)有限公司 preparation method of triptolide derivative
CN110551171B (en) * 2018-05-31 2021-07-27 欣凯医药化工中间体(上海)有限公司 Preparation method of triptolide derivative
CN110551170B (en) * 2018-05-31 2022-04-22 欣凯医药化工中间体(上海)有限公司 Synthesis method of C-19 single-acyl triptolide derivative

Similar Documents

Publication Publication Date Title
CN104513187A (en) Ezetimibe synthesis method and Ezetimibe intermediate synthesis method
Zhang et al. Enantioselective biomimetic cyclization of 2′-hydroxychalcones to flavanones
CN106188078A (en) A kind of chiral spiro hydroxyindole benzopyrone the synthetic method of 3,4 dihydropyrane compounds
CN107805232A (en) A kind of synthetic method of the derivative containing thiomethylfuran
CN108530510A (en) A kind of C19- is acylated the preparation method of triptolide
Peralta-Hernández et al. A practical one-pot radical-ionic sequence for the preparation of epoxides: application to the synthesis of unnatural polyhydroxylated alkaloids
CN107056795A (en) A kind of loop coil hydroxyindole pentamethylene and β lactones compound synthesis methods
JP2013234194A (en) Method of producing c-glycoside derivative
CN110511193B (en) Alpha-ketothioamide compound and synthetic method thereof
JP6548214B2 (en) Catalyst having an aminosalicylaldimine ligand coordinated to metal and method for producing iodocyclic compound using the same
CN106032381A (en) Industrial production method of midazolam derivative
CN110804012B (en) Method for reducing mercaptal or thioketone for desulfurization
Lemus et al. Lewis acid catalyzed enlargement of cyclic β‐alkoxyenals and one‐pot synthesis of polyfunctional enoxysilanes derived from aucubin with trimethylsilyldiazomethane
CN106187837B (en) Florfenicol intermediate, preparation method thereof and preparation method of florfenicol
JP2011068587A (en) New aminoalcohol derivative salt, asymmetric organic molecule catalyst having aminoalcohol derivative salt structure and method for producing optically active compound with the asymmetric organic molecule catalyst
CN110551170B (en) Synthesis method of C-19 single-acyl triptolide derivative
KR20100072437A (en) Aza-bicyclo[2.2.1]heptene derivatives, process for preparing thereof and process for preparing oseltamivir intermediate using the same
WO2018214327A1 (en) Preparation method for anti-cancer drug lanosterol derivative
CN112745275B (en) Synthetic method of 1,3, 4-oxadiazole heterocyclic compound
CN104628718A (en) Method for synthesizing scopolamine and salts thereof
CN105624215B (en) Novel method for synthesizing calcipotriol
CN114539125B (en) Synthesis method of paciclovir intermediate
CN110294719B (en) Synthesis method of thiazolidone compound
CN104140376B (en) A kind of method of synthesizing 5-ALA
CN107200729A (en) One kind 4(2 methoxyphenyls)‑5‑(2 pyridine radicals) 3 amido isoxazoles preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180914

RJ01 Rejection of invention patent application after publication